Who Paid My Doc
George Kochik
Adolescent Medicine Wexford, PA Medical Doctor
NPI 1164496576 CMS profile 1291020
2400 Corporate Dr Ste 100, Suite 100, Wexford, PA 15090
General payments
$66
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, George Kochik of Wexford, PA is reported in the CMS Open Payments database as having received $66 across 4 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $17 | 1 | |
| 2022 | General | $15 | 1 | |
| 2020 | General | $18 | 1 | |
| 2019 | General | $16 | 1 |
Beside peers
- George Kochik
- Adolescent Medicine median
- Middle half of Adolescent Medicine
- National median
In program year 2025, general payments to George Kochik were reported at $0. Among 40 Adolescent Medicine profiles paid that year, the median was $135 and the middle half received between $78 and $573.
Show as a table
| Year | George Kochik | Adolescent Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $16 | $112 | $24–$444 | $163 |
| 2020 | $18 | $80 | $35–$250 | $114 |
| 2021 | $0 | $229 | $55–$448 | $132 |
| 2022 | $15 | $162 | $35–$492 | $149 |
| 2023 | $17 | $182 | $54–$507 | $160 |
| 2024 | $0 | $142 | $59–$362 | $164 |
| 2025 | $0 | $135 | $78–$573 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 158 drugsPart D claims
12,457
Drug cost
$803,725
Branded share of claims
17.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 197 | $192,527 | |
| Jardiance Empagliflozin | Brand | 153 | $133,009 | |
| Ozempic Semaglutide | Brand | 74 | $88,750 | |
| Xarelto Rivaroxaban | Brand | 55 | $71,509 | |
| Januvia Sitagliptin Phosphate | Brand | 20 | $31,659 | |
| Rexulti Brexpiprazole | Brand | 15 | $26,237 | |
| Breo Ellipta Fluticasone/Vilanterol | Brand | 67 | $25,793 | |
| Entresto Sacubitril/Valsartan | Brand | 21 | $24,104 | |
| Combivent Respimat Ipratropium/Albuterol Sulfate | Brand | 17 | $14,546 | |
| Tradjenta Linagliptin | Brand | 11 | $11,998 |
The 10 drugs with the highest cost, of 158 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$55,192
Medicare patients
228
Services billed
741
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 56% | |
| Arthritis | 40% | |
| Diabetes | 27% | |
| Ischemic heart disease | 24% | |
| Atrial fibrillation | 14% | |
| Cancer | 13% | |
| Depression | 12% | |
| COPD | 11% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Pcv20 vaccine im 90677 | Office | 15 | 15 | $4,335 |
| Influenza vaccine, trivalent derived from recombinant dna 90673 | Office | 41 | 41 | $2,009 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
4 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adolescent Medicine in Pennsylvania
Joan Addley
Adolescent Medicine · Philadelphia, PA
Joseph Trompeter
Adolescent Medicine · Carnegie, PA
Gerard Margiotti
Adolescent Medicine · Trevose, PA
Gregory Anderson
Adolescent Medicine · Pittsburgh, PA
Matthew Ebling
Adolescent Medicine · Lancaster, PA
Amy Hursh
Adolescent Medicine · Pittsburgh, PA
Related records
Adolescent Medicine in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Adolescent Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.